Keystone Bio has identified and is targeting a "one of a kind Inflammapath ", the keystone pathogen of chronic inflammation that’s been shown to initiate and advance Atherosclerosis, Heart disease and Alzheimer's disease.Keystone Bio is a nextgen PharmaBiome biotech that has identified and is targeting a "one of a kindInflammapath ", the keystone pathogen of chronic inflammation that’s been shown to initiate and advance Atherosclerosis, Heart disease and Alzheimer's disease.

Pharmaceutical

Health Care

Biotechnology

Keystone Bio

Keystone Bio's headquarters in Saint Louis, MO, United States

Marc Penn

Michael Rafii

W. Sue T. Griffin

Rita Colwell

William J. Ray

Garth Erhlich

Robert Rissman

Edward J. Zuckerberg

Jan Potempa

Shaun Lonergan

Description

People

Jobs